Latest News and Press Releases
Want to stay updated on the latest news?
-
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
DURHAM, N.C., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Velocity Clinical Research (Velocity), the leading fully integrated site organization, today announces the appointment of Andrew (Drew) Reina as Chief...
-
Palantir is strategically moving into the clinical trials industry and Velocity is one of its first partners.
-
DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new...
-
DURHAM, Carolina del Norte, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research, la organización líder de centros clínicos totalmente integrados, anuncia el nombramiento de Renata...
-
DURHAM, Carolina do Norte, Nov. 21, 2024 (GLOBE NEWSWIRE) -- A Velocity Clinical Research, organização líder do mercado no segmento de centros clínicos totalmente integrados, anuncia a nomeação de...
-
DURHAM, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research, the leading fully integrated clinical site organization, announces the appointment of Renata Berardocco as Executive Vice...
-
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, today announces the appointment of Rachael Buck Ph.D. as...
-
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, today announces it has appointed Mike Zaranek as Chief...
-
DURHAM, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, and Luminis Health, a non-profit health system providing...
-
• nmible’s solution expected to save more than 650 working days per year, administering payments • Velocity spends $20 million a year in patient stipends LONDON, Jan. 24, 2024 (GLOBE NEWSWIRE)...